Trial
NCT06124144
Safety and Drug Absorption of Orally Administered Oleylphosphocholine (OlPC) in Healthy Adults
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
University Hospital Tuebingen
Collaborators
—
Condition
Leishmaniasis
Intervention
Oleylphosphocholine
Why stopped
The risk-benefit ratio changed
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-03-12